GlassScriptPhysician profile
Stephen A Rosenberg
NPI 1235125709
$1,542.11
in general payments reported to CMS, 2019-2025
25 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $53.81 · 2021: $230 · 2022: $263 · 2023: $310 · 2024: $206 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $403.48 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Astellas Pharma US INC | $329.35 | 2019-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $118.73 | 2021-2025 | |
| Organon LLC | $91.33 | 2021-2025 | Nexplanon, Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $74.91 | 2019-2023 | |
| Exeltis, USA INC. | $53.74 | 2021-2025 | Slynd |
| Millicent US INC | $39.24 | 2024-2025 | Femlyv, Intrarosa |
| Merck Sharp & Dohme LLC | $36.78 | 2019-2020 | |
| Aspira Women'S Health INC | $32.78 | 2024 | Ova1 |
| Masimo Corporation | $32.32 | 2019 | |
| Boston Scientific Corporation | $30.46 | 2019-2022 | |
| Myovant Sciences INC. | $29.96 | 2022 | |
| Channel Medsystems, INC. | $27.74 | 2024-2025 | |
| Pfizer INC. | $25.96 | 2023 | |
| Shield Therapeutics INC | $25.36 | 2023 | Accrufer |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $24.31 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $23.73 | 2022 | |
| Meditrina | $23.47 | 2023 | |
| Novo Nordisk INC | $22.21 | 2025 | Wegovy |
| Optumhealth Care Solutions, LLC | $19.73 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Acella Pharmaceuticals, LLC | $17.14 | 2025 | NP Thyroid 60 |
| Coopersurgical, INC. | $15.91 | 2019 | |
| Therapeuticsmd, INC. | $15.19 | 2022 | |
| Biogen, INC. | $14.94 | 2019 | |
| Scynexis, INC. | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.